Participant flow

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia · Source last updated 2018-05-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Arm 1: Methotrexate 30 mg/m2 IM weekly

   id

   FG000

   title

   Arm 1: Methotrexate 30 mg/m2 IM Weekly

2. description

   Arm 2: Dactinomycin 1.25 mg/m2 IV push every 2 weeks

   id

   FG001

   title

   Arm 2: Dactinomycin 1.25 mg/m2 IV Push Every 2 Weeks

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         2

      type

      Ineligible cell types

   2. reasons

      1. group Id

         FG000

         num Subjects

         8

      2. group Id

         FG001

         num Subjects

         5

      type

      Did not meet criteria for persistence

   3. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         1

      type

      WHO score > 6

   4. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         3

      type

      Inadequate documentation of disease

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         120

      2. group Id

         FG001

         num Subjects

         120

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         107

      2. group Id

         FG001

         num Subjects

         109

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         13

      2. group Id

         FG001

         num Subjects

         11

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

This trial opened to patient accrual on 6/14/1999 and closed to accrual on 2/26/2007.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice